These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28983247)

  • 1. Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1.
    Tuure L; Hämäläinen M; Whittle BJ; Moilanen E
    Front Pharmacol; 2017; 8():646. PubMed ID: 28983247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1).
    Tuure L; Hämäläinen M; Nummenmaa E; Moilanen T; Moilanen E
    Int Immunopharmacol; 2019 Jun; 71():139-143. PubMed ID: 30897501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1.
    Tuure L; Hämäläinen M; Moilanen E
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia.
    Wang X; Nelin LD; Kuhlman JR; Meng X; Welty SE; Liu Y
    Life Sci; 2008 Nov; 83(19-20):671-80. PubMed ID: 18845168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.
    Chen P; Li J; Barnes J; Kokkonen GC; Lee JC; Liu Y
    J Immunol; 2002 Dec; 169(11):6408-16. PubMed ID: 12444149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells.
    Turpeinen T; Nieminen R; Moilanen E; Korhonen R
    J Pharmacol Exp Ther; 2010 Apr; 333(1):310-8. PubMed ID: 20089808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice.
    Nishizawa N; Ito Y; Eshima K; Ohkubo H; Kojo K; Inoue T; Raouf J; Jakobsson PJ; Uematsu S; Akira S; Narumiya S; Watanabe M; Majima M
    J Hepatol; 2018 Jul; 69(1):110-120. PubMed ID: 29458169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucocorticoid dexamethasone alleviates allergic inflammation through a mitogen-activated protein kinase phosphatase-1-dependent mechanism in mice.
    Lehtola T; Nummenmaa E; Nieminen R; Hämäläinen M; Vuolteenaho K; Moilanen E
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):686-694. PubMed ID: 38439200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MKP-1 negatively regulates LPS-mediated IL-1β production through p38 activation and HIF-1α expression.
    Talwar H; Bauerfeld C; Bouhamdan M; Farshi P; Liu Y; Samavati L
    Cell Signal; 2017 Jun; 34():1-10. PubMed ID: 28238855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts.
    Yucel-Lindberg T; Olsson T; Kawakami T
    Cell Signal; 2006 Dec; 18(12):2131-42. PubMed ID: 16766159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
    Toh ML; Yang Y; Leech M; Santos L; Morand EF
    Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microglia.
    de Oliveira AC; Yousif NM; Bhatia HS; Hermanek J; Huell M; Fiebich BL
    J Neuroinflammation; 2016 Jan; 13():11. PubMed ID: 26780827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress.
    Avendaño MS; García-Redondo AB; Zalba G; González-Amor M; Aguado A; Martínez-Revelles S; Beltrán LM; Camacho M; Cachofeiro V; Alonso MJ; Salaices M; Briones AM
    Hypertension; 2018 Aug; 72(2):492-502. PubMed ID: 29891646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38α MAPK inhibits stretch-induced JNK activation in cardiac myocytes through MKP-1.
    Feng H; Gerilechaogetu F; Golden HB; Nizamutdinov D; Foster DM; Glaser SS; Dostal DE
    Int J Cardiol; 2016 Jan; 203():145-55. PubMed ID: 26512830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.
    Chi H; Barry SP; Roth RJ; Wu JJ; Jones EA; Bennett AM; Flavell RA
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2274-9. PubMed ID: 16461893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
    Martin EM; Jones SL
    Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages.
    Zhu QY; Liu Q; Chen JX; Lan K; Ge BX
    J Immunol; 2010 Dec; 185(12):7435-42. PubMed ID: 21068409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.